Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

219674-97-2Maribavir Impurity 7

● Auf Lager

Katalog-Nr.::	VE0028053
CAS-Nr.::	219674-97-2
Summenformel::	C15H19Cl2N3O4
Molare Masse::	376.24 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 219674-97-2

Parent drug

Maribavir

IUPAC-Name

(2R,3R,4R,5S)-2-(5,6-Dichloro-2-(isopropylamino)-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

Pharmacopeial Synonyms

N/A

Synonyme

N/A

SMILES

CC(NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H](O[C@H]3CO)[C@H](O)[C@H]3O)C

InChI

InChI=1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13+,14+/m0/s1

Beschreibung

Maribavir Impurity 7 (CAS 219674-97-2) is a process and degradation-related impurity arising within maribavir synthetic routes, characterized by a distinct chromatographic retention profile and a reproducible high resolution mass spectral fingerprint. Structural confirmation is supported by 1D and 2D NMR, LC-MS and UV absorbance data, revealing functional motifs closely related to the parent scaffold that can affect ionization and detectability. Its physicochemical behavior may complicate chromatographic separation and quantification, necessitating optimized method development and orthogonal analytical approaches. Comprehensive spectral documentation and batch-specific analytical data enable confident identification and trace-level monitoring.